Migraine is more than just a headache. It is the third most common disease in the world, affecting 1 billion people worldwide. There is currently no treatment which works to prevent migraine for everyone with the condition, which causes significant, debilitating pain that can be accompanied by sensory disturbances. The Relief study will investigate whether tricaprilin works to prevent migraine in people who have frequent migraine attacks.